Pharmaceutical CEOs Aren't Always Aware of Public Perception

Meg Urry: The ball is in pharma's court to change that narrative if they desire to and if they have the power to, because things have not been going their way as we've discussed kind of at length. "I think it's silly to look at the midterm elections as a referendum on the IRA," she says. 'It does seem to be a relatively popular piece of legislation'